Enhancing Breast Cancer Treatment with T-oligos and Radiation
Author Information
Author(s): Weng Desheng, Cunin Monique C, Song Baizheng, Price Brendan D, Eller Mark S, Gilchrest Barbara A, Calderwood Stuart K, Gong Jianlin
Primary Institution: Boston University School of Medicine
Hypothesis
T-oligo treatment sensitizes tumor cells to ionizing radiation.
Conclusion
Pretreatment with T-oligo sensitizes mammary tumor cells to radiation in both in vitro and in vivo settings with minimal or no normal tissue side effects.
Supporting Evidence
- T-oligo treatment enhanced apoptosis and senescence in irradiated tumor cells.
- Combined T-oligo and radiation treatment significantly reduced tumor growth in mice.
- No detectable side effects were observed in normal tissues after treatment.
Takeaway
Using a special treatment called T-oligos can help make cancer cells more sensitive to radiation, which can help shrink tumors without hurting normal cells.
Methodology
Mammary tumor cells were treated with T-oligo followed by ionizing radiation, and various assays were conducted to assess cell growth, apoptosis, and tumorigenesis.
Potential Biases
Potential conflicts of interest due to co-authors having equity in a related start-up company.
Limitations
The study primarily used murine models, which may not fully replicate human responses.
Participant Demographics
Female C57BL/6 mice, six to eight weeks old.
Statistical Information
P-Value
0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website